Imidazolylmethyl and Pyrazolylmethyl Heteroaryl Derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 5, 2008
app pub date -
Jan 19, 2006
filing date -
Jan 21, 2005
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Compounds of Formula I and Formula II are provided, as are methods for their preparation. The variables Y, Z.sub.1, Z.sub.2, Z.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 and Ar in the above formula are defined herein. Such compounds may be used to modulate ligand binding to GABA.sub.A receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) disorders in humans, domesticated companion animals and livestock animals. Compounds provided herein may be administered alone or in combination with one or more other CNS agents to potentiate the effects of the other CNS agent(s). Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting GABA.sub.A receptors (e.g., receptor localization studies).
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully